Nucleos(t)ide analogs continuation is not associated with a lower risk of HBsAg seroreversion following PEG-IFN-induced HBsAg loss

Abstract Background/Aims It is unclear whether nucleos(t)ide analogs (NUCs) continuation provides clinical benefits following HBsAg seroclearance with pegylated interferon (PEG-IFN)-based therapy. This study aims to investigate the role of NUCs continuation in HBsAg seroreversion. Methods Patients w...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Na Gao, Haishi Wu, Bin Li, Huiying Yu, Lili Wu, Jing Zhang, Nan Zhang, Bingliang Lin, Qiyi Zhao, Zhiliang Gao
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	BMC 2025-03-01
Serie:	Virology Journal
Soggetti:	Chronic hepatitis B Nucleos(t)ide analogs Seroreversion Functional cure
Accesso online:	https://doi.org/10.1186/s12985-025-02700-2
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!